Scholars Central

Research articlePublished 5 Aug 2014

Novel Dual Magnetic Drug Targeting and Hyperthermia Therapy in Hepatocellular Carcinoma with Thermosensitive Polymer-Coated Nanoparticles

Authors: Chang PEJ, Purushotham S, Rumpel H, Kee IHC, Ng RTH, Chow PKH, Ramanujan RV, Tan CK

Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore; School of Materials Science and Engineering, Nanyang Technological University, Singapore; Department of Diagnostic Radiology, Singapore General Hospital, Singapore; Department of Experimental Surgery, Singapore General Hospital, Singapore; Department of General Surgery, Singapore General Hospital, Singapore; Duke-NUS Graduate Medical School, Singapore

Journal of Gastrointestinal & Digestive System

Volume 4 · Issue 4 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Magnetic drug targeting (MDT) uses magnetic fields to localize magnetic nanoparticles (MNP) to tumor. Once localized, applying an alternating magnetic field (AMF) to the MNPs generates heat energy. Poly-N-isopropylacrylamide (PNIPA) is a thermosensitive polymer that contracts when heated, releasing any drugs which are bound to it. Utilizing these properties, MNP coated with PNIPA polymer on to which doxorubicin is loaded can be localized to hepatocellular carcinoma (HCC) with an external magnetic field. Application of an AMF will then generate localized magnetic hyperthermia (MH) within the tumor, thus releasing bound doxorubicin. This study explores this novel drug delivery model which can be used for targeted dual therapy (MDT and MH) of HCC. Aim: To demonstrate that doxorubicin-loaded-PNIPA-coated-MNP can be delivered intra-arterially to target HCC in a rat model and that heat is generated and doxorubicin is released when an AMF is applied. Methods: Morris hepatoma cells are implanted into the livers of buffalo rats. HCC development is confirmed on MRI using a specially-constructed rat-MRI coil. 0.5 ml of doxorubicin-loaded-PNIPA-coated-MNP solution is injected into the hepatic artery and localization of MNP in HCC is confirmed with MRI. Rats are sacrificed for histology of liver and other organs. AMF is applied to doxorubicin-loaded-PNIPA-coated-MNP solution and the temperature measured to demonstrate local hyperthermia in vitro. The amount of doxorubicin released is measured by spectrophotometry. Results: Successful intra-arterial delivery of MNP was confirmed on post-injection MRI. On histology, iron particles were seen in HCC but not in normal liver or other organs. When AMF was applied, temperature of the suspension reached the target temperature of 42°C within 5 minutes and remained within hyperthermia range(42°C-48°C) for 15 minutes. During this period of hyperthermia, 4.7% (~71 μg) of loaded doxorubicin was released. Conclusions: We have demonstrated in a rat model the feasibility of intra-arterial doxorubicin-loaded-PNIPA-coated-MNP for synergistic dual therapy of HCC using targeted hyperthermia and doxorubicin.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Gastrointestinal & Digestive System.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Gastrointestinal & Digestive System
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Chang PEJ”
  • BylineArticles whose byline prints “Purushotham S”
  • BylineArticles whose byline prints “Rumpel H”
  • BylineArticles whose byline prints “Kee IHC”
  • BylineArticles whose byline prints “Ng RTH”
  • BylineArticles whose byline prints “Chow PKH”
  • BylineArticles whose byline prints “Ramanujan RV”
  • BylineArticles whose byline prints “Tan CK”